BCL2L1 Antikörper
Kurzübersicht für BCL2L1 Antikörper (ABIN965653)
Target
Alle BCL2L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- BCL-XL (Ab-62) antibody detects endogenous levels of total BCL-XL protein.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- This antiserum was produced against synthesized non-phosphopeptide derived from human BCL-XL around the phosphorylation site of serine 62 (A-D-SP-P-A).
-
-
-
-
Applikationshinweise
- WB: 1:500~1:1000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 100ug/100ul.
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
-
: "Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis." in: Science (New York, N.Y.), Vol. 275, Issue 5302, pp. 983-6, (1997) (PubMed).
: "X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death." in: Nature, Vol. 381, Issue 6580, pp. 335-41, (1996) (PubMed).
-
: "Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis." in: Science (New York, N.Y.), Vol. 275, Issue 5302, pp. 983-6, (1997) (PubMed).
-
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Andere Bezeichnung
- BCL-XL
-
Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Target
-